Dr. Christopher L. Daniels, MD
Interventional Cardiology (Interventional Cardiology Physician)
116 Mimosa Dr
Thomasville, GA 31792
Who else practices at this address →
Thomas County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Meharry Medical College School of Medicine (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,396
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Meharry Medical College School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
GA license 071484 · FL license ME120935 -
Cardiovascular Disease Physician
LA license 201390
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Archbold Memorial Hospital Thomasville, GA
- Colquitt Regional Medical Center Moultrie, GA
- Grady General Hospital Cairo, GA
- Memorial Hospital and Manor Bainbridge, GA
- Archbold Brooks Quitman, GA
Medical groups
- John D Archbold Memorial Hospital Inc (61 clinicians)
- Ccsg, Inc (26 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,396
- Services billed
- 2,682
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 751 | 645 |
| Established patient office or other outpatient visit, 30-39 minutes | 533 | 430 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 236 | 217 |
| Ultrasound of both sides of head and neck blood flow | 188 | 187 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 185 | 170 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 111 | 111 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 84 | 52 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 78 | 12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 73 | 36 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | 63 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Thomasville, GA | 1,156 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Thomasville, GA | 922 |
| Atorvastatin Calcium Other prescribers in Thomasville, GA | 910 |
| Eliquis (apixaban) Other prescribers in Thomasville, GA | 605 |
| Carvedilol Other prescribers in Thomasville, GA | 536 |
| Losartan Potassium Other prescribers in Thomasville, GA | 474 |
| Ranolazine Er (ranolazine) Other prescribers in Thomasville, GA | 468 |
| Rosuvastatin Calcium Other prescribers in Thomasville, GA | 431 |
| Furosemide Other prescribers in Thomasville, GA | 417 |
| Amlodipine Besylate Other prescribers in Thomasville, GA | 358 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 109 payments worth $5,212 in total to this clinician.
| Abbott Laboratories | $1,742 |
|---|---|
| Medtronic, Inc. | $1,511 |
| Shockwave Medical, Inc | $437 |
| Novartis Pharmaceuticals Corporation | $326 |
| Penumbra, Inc. | $267 |
| Abiomed | $222 |
| Stryker Corporation | $140 |
| Amgen Inc. | $103 |
| Food and Beverage | $2,961 |
|---|---|
| Travel and Lodging | $2,251 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $1,012 |
| Medtronic, Inc. Aug 22, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $376 |
| Medtronic, Inc. Sep 12, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $299 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $187 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $127 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $78.45 |
| Medtronic, Inc. Sep 13, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $56.39 |
| Medtronic, Inc. Sep 14, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $54.12 |
| Medtronic, Inc. Sep 12, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $52.58 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $17,876 in research payments for these studies, mostly to the institutions running them.
- A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Novartis Pharmaceuticals Corporation - A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Dis…
Novartis Pharmaceuticals Corporation - Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)
Alnylam Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.